RENOVORX, INC. (RNXT)
RenovoRx Receives Notice of Allowance for New U.S. Patent Covering RenovoCath®, an Advanced Dual-Occlusion Catheter, for Targeted Therapeutic Drug-Delivery for Cancer Treatment
RenovoRx Receives Notice of Allowance for New U.S. Patent Covering RenovoCath®, an Advanced Dual-Occlusion Catheter, for Targeted Therapeutic Drug-Delivery for Cancer Treatment
Doug Bergeron Comments on Latest Self-Serving Tactics by Ethan Allen Board
Supporting Nagakute Citys Weekend and Holiday School Club Activities Through Professional Management, Contributing to Teacher Workstyle Reform and Enriching Sports and Cultural Opportunities for Children
Prevail Bank Selects Jack Henry to Differentiate Through Open Ecosystem and AI Innovation
Sol-Gel Reports Second Quarter 2026 Financial Results and Provides Corporate Updates
ICON Releases 2025 ICON Cares Report, Highlighting Progress in Patient Impact, Innovation and Sustainability
Herc Rentals Publishes 2026 Corporate Citizenship Report
Enovix to Double Korea Drone Battery Capacity
BTCS Reports Gross Profit of $1.5 Million and 61% Gross Margin for Second Quarter 2026
Amaze Holdings Enters Letter of Intent for Strategic Investment in Live Social Creator Platform C2